BioSpace News Archive

NextGate, the global leader in healthcare enterprise identification, announced today a strategic partnership with IDology, a pioneer and trusted leader in identity verification, authentication and fraud prevention.

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27, 2019 at 11:30 a.m. Eastern / 8:30 a.m. Pacific in New York City.

The German based contract developer and contract manufacturer for transdermal patches and oral films moves closer to their customers and partners in the United States.

SOC Telemed (SOC), the leader in acute care telemedicine, today announces its selection by Prime Healthcare to deliver a scalable and flexible technology platform for Prime’s national telemedicine operations.

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a biopharmaceutical company specializing in oxygen therapeutics, today announced results from a pilot study on liver transplants conducted at the Netherlands largest transplantation center, the University Medical Center in Groningen (UMCG) under the direction of the lead investigator Professor Robert Porte, Head of Hepatobiliary Surgery and Liver Transplantation.

PTC Therapeutics, Inc. announced the launch of the fifth annual STRIVE grant award program for Duchenne Muscular Dystrophy.

Coating Technology offers Improved Lens Wettability for Patients with Challenging Vision Needs

Going forward, OLLIF should be considered a preferred option for fusions of the lumbar spine.

Avanir Pharmaceuticals, Inc., an indirect subsidiary of Otsuka Pharmaceutical Co., Ltd., has reached an agreement in principle to resolve an investigation by the United States Department of Justice related to certain of Avanir’s sales and marketing practices for its product NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) 20mg/10mg capsules prior to 2017.

Henry Schein, Inc. announced that the Company will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York on Wednesday, February 27, 2019, at 11:00 a.m. Eastern time.